Medpace Holdings, Inc. (MEDP)

USD 331.0

(-5.02%)

Total Debt Summary of Medpace Holdings, Inc.

  • Medpace Holdings, Inc.'s latest annual total debt in 2023 was 142.12 Million USD , down -24.75% from previous year.
  • Medpace Holdings, Inc.'s latest quarterly total debt in 2024 Q2 was 153.72 Million USD , up 12.9% from previous quarter.
  • Medpace Holdings, Inc. reported annual total debt of 188.86 Million USD in 2022, up 44.21% from previous year.
  • Medpace Holdings, Inc. reported annual total debt of 130.96 Million USD in 2021, up 13.74% from previous year.
  • Medpace Holdings, Inc. reported quarterly total debt of 153.72 Million USD for 2024 Q2, up 12.9% from previous quarter.
  • Medpace Holdings, Inc. reported quarterly total debt of 136.15 Million USD for 2024 Q1, down -4.2% from previous quarter.

Annual Total Debt Chart of Medpace Holdings, Inc. (2023 - 2014)

Historical Annual Total Debt of Medpace Holdings, Inc. (2023 - 2014)

Year Total Debt Total Debt Growth
2023 142.12 Million USD -24.75%
2022 188.86 Million USD 44.21%
2021 130.96 Million USD 13.74%
2020 115.14 Million USD 154.67%
2019 45.21 Million USD -43.29%
2018 79.72 Million USD -64.03%
2017 221.61 Million USD 35.42%
2016 163.64 Million USD -56.69%
2015 377.88 Million USD -23.12%
2014 491.51 Million USD 0.0%

Peer Total Debt Comparison of Medpace Holdings, Inc.

Name Total Debt Total Debt Difference
Bionano Genomics, Inc. 87.94 Million USD -61.6%
Prenetics Global Limited 2.36 Million USD -5898.258%
Star Equity Holdings, Inc. 3.6 Million USD -3837.988%
CareDx, Inc 34.22 Million USD -315.306%
Exact Sciences Corporation 2.55 Billion USD 94.437%
Exagen Inc. 23.72 Million USD -499.14%
Inotiv, Inc. 417.64 Million USD 65.97%
Guardant Health, Inc. 1.35 Billion USD 89.502%
Biodesix, Inc. 60.69 Million USD -134.173%
BioNexus Gene Lab Corp. 133.39 Thousand USD -106442.224%
Precipio, Inc. 1.11 Million USD -12634.946%
iSpecimen Inc. 196.24 Thousand USD -72321.068%
Natera, Inc. 441.99 Million USD 67.845%
Aspira Women's Health Inc. 2.26 Million USD -6171.933%
Standard BioTools Inc. 98.21 Million USD -44.712%
23andMe Holding Co. 76.51 Million USD -85.744%
Castle Biosciences, Inc. 15.31 Million USD -828.295%
Personalis, Inc. 48.96 Million USD -190.27%
Aclaris Therapeutics, Inc. 426 Thousand USD -33261.972%
Applied DNA Sciences, Inc. 1.23 Million USD -11382.194%
OpGen, Inc. 13.04 Million USD -989.583%
T2 Biosystems, Inc. 49.49 Million USD -187.127%
Myriad Genetics, Inc. 145 Million USD 1.985%
ICON Public Limited Company 3.93 Billion USD 96.391%
NeoGenomics, Inc. 611.67 Million USD 76.765%
Star Equity Holdings, Inc. 3.6 Million USD -3837.988%
IDEXX Laboratories, Inc. 947.88 Million USD 85.006%
RadNet, Inc. 1.49 Billion USD 90.469%
MDxHealth SA 41.26 Million USD -244.413%
Psychemedics Corporation 2.29 Million USD -6084.595%
Illumina, Inc. 2.26 Billion USD 93.717%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 94.06 Million USD -51.083%
DarioHealth Corp. 29.54 Million USD -381.101%
Fulgent Genetics, Inc. 14.9 Million USD -853.391%
Sera Prognostics, Inc. 1.85 Million USD -7549.193%
ENDRA Life Sciences Inc. 394.4 Thousand USD -35934.716%
OPKO Health, Inc. 326.56 Million USD 56.48%
Neogen Corporation 906.23 Million USD 84.317%
Intelligent Bio Solutions Inc. 871.44 Thousand USD -16208.868%
Prenetics Global Limited 2.36 Million USD -5898.258%
Mainz Biomed B.V. 7.42 Million USD -1815.19%
bioAffinity Technologies, Inc. 1.57 Million USD -8902.818%
Trinity Biotech plc 67.42 Million USD -110.779%
Neuronetics, Inc. 62.47 Million USD -127.49%
Sotera Health Company 2.32 Billion USD 93.893%
bioAffinity Technologies, Inc. 1.57 Million USD -8902.818%